Truvestments Capital LLC Makes New Investment in Axcelis Technologies, Inc. (NASDAQ:ACLS)

Truvestments Capital LLC bought a new position in Axcelis Technologies, Inc. (NASDAQ:ACLS) in the third quarter, HoldingsChannel reports. The fund bought 658 shares of the semiconductor company’s stock, valued at approximately $69,000.

Other large investors have also made changes to their positions in the company. Signaturefd LLC grew its stake in shares of Axcelis Technologies by 348.9% during the 2nd quarter. Signaturefd LLC now owns 211 shares of the semiconductor company’s stock valued at $30,000 after purchasing an additional 164 shares during the period. Blue Trust Inc. grew its stake in shares of Axcelis Technologies by 223.8% during the 2nd quarter. Blue Trust Inc. now owns 272 shares of the semiconductor company’s stock valued at $39,000 after purchasing an additional 188 shares during the period. Ashton Thomas Private Wealth LLC bought a new stake in shares of Axcelis Technologies during the 2nd quarter valued at about $39,000. Meeder Asset Management Inc. bought a new stake in shares of Axcelis Technologies during the 2nd quarter valued at about $69,000. Finally, Advisors Asset Management Inc. grew its stake in shares of Axcelis Technologies by 17.5% during the 1st quarter. Advisors Asset Management Inc. now owns 670 shares of the semiconductor company’s stock valued at $75,000 after purchasing an additional 100 shares during the period. 89.98% of the stock is currently owned by institutional investors.

Axcelis Technologies Trading Down 3.9 %

Shares of NASDAQ:ACLS opened at $74.45 on Wednesday. Axcelis Technologies, Inc. has a 12-month low of $69.35 and a 12-month high of $158.61. The company has a current ratio of 4.45, a quick ratio of 3.29 and a debt-to-equity ratio of 0.04. The company has a market cap of $2.42 billion, a PE ratio of 11.01, a price-to-earnings-growth ratio of 2.34 and a beta of 1.60. The stock has a 50 day moving average of $91.06 and a 200 day moving average of $110.67.

Analyst Ratings Changes

A number of research firms have issued reports on ACLS. Needham & Company LLC restated a “hold” rating on shares of Axcelis Technologies in a research note on Friday, November 8th. B. Riley cut their price objective on Axcelis Technologies from $190.00 to $165.00 and set a “buy” rating for the company in a research note on Friday, August 2nd. Finally, Benchmark downgraded Axcelis Technologies from a “buy” rating to a “hold” rating in a research note on Friday, November 8th. Three analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $167.33.

About Axcelis Technologies

Axcelis Technologies, Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and Asia Pacific. The company offers high energy, high current, and medium current implanters for various application requirements.